PubMed · 3909812
Renal osteodystrophy--pathogenesis and treatment.
Abstract
Histologic bone changes of osteitis fibrosa and osteomalacia are commonly present in patients with end-stage renal disease. Although many patients are not symptomatic from these bone changes, some patients are severely disabled. Altered metabolism of vitamin D, calcium, phosphorus, and parathyroid hormone occurs in renal failure and contributes to the development of uremic bone disease. This article reviews the current theories of pathogenesis and treatment of renal osteodystrophy. In addition, the clinical presentation, pathogenesis, and treatment of the various aluminum-associated osteomalacic syndromes in uremia are discussed.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H M Cushner, N D Adams. 1985. Renal osteodystrophy--pathogenesis and treatment.. https://doi.org/10.1097/00000441-198512000-00003
Cite the original work for its findings. Save a collection to share your selection of sources.